|
Compound Information
|
| ID |
498 |
| TrivialName |
notoginsenoside NL-H2 |
| Type |
C17-side chain varied |
| MF |
C₄₇H₈₀O₁₈ |
| MolecularWeight |
933.139 |
| IUPACName |
NT |
| m/z |
977.5308 |
| Retention Time |
20.75 |
| CCS |
316.72 |
| Adducts |
[M−H+HCOOH]− |
| Isomeric SMILES |
CC1(C)[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)CC[C@@]3(C)C1CC[C@]4(C)C3C[C@@H](O)C5[C@@]4(C)CCC5[C@@](CC[C@H](O)C(C)=C)(C)O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]7[C@H](O)[C@@H](O)[C@H](O)CO7)O6 |
| Canonical SMILES |
C=C(C)C(O)CCC(C)(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4O)C(C)(C)C3CCC12C |
| Source |
PN |
| Functions |
protective effect (nerve cell injury) |
| Year |
2020 |
| References |
Ruan et al. (2020)
|
| Structure |
|